why choose us

First received: January 05, 2024

Clinical Trial: Comparison of Rimegepant and Placebo for Pain in IBS

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Irritable Bowel Syndrome

Study Type: INTERVENTIONAL


Official Title: Rimegepant, a CGRP Antagonist, in the Treatment of Visceral Sensation and Chronic Abdominal Pain: A Pilot Study

Brief Summary: The primary aim of this study is to evaluate the efficacy of rimegepant on abdominal pain scores in participants with non-constipation IBS.

Read more